(Q36058291)
Statements
Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401 (English)
William Kevin Kelly
Michael Carducci
Daniel George
John F Mahoney
Walter M Stadler
J Paul Monk
Ellen Kaplan
Nicholas J Vogelzang
Eric J Small
26 March 2012
1 reference
1 reference
1 reference